Monsanto to Pursue Divestiture of POSILAC
Last update: 10:17 a.m. EDT Aug. 6, 2008
ST. LOUIS, Aug 06, 2008 /PRNewswire via COMTEX/ -- ST. LOUIS, Aug. 6 /PRNewswire-FirstCall/-- Monsanto Company (MON:
MON 107.86, -1.54, -1.4%) announced today that it is pursuing a divestiture of its dairy product, POSILAC(R) bovine somatotropin, in the upcoming months
(
Read more... )